VIP (Vasoactive Intestinal Peptide), also known as vasodilatory enteric peptide, is a type of neurotransmitter that exists in the central nervous system and enteric nervous system. It consists of 28 amino acids and is mainly released by enteric neurons. It has a dual role in the organism, as both a alimentary hormone and a neuropeptide.
VIP has various functions, such as dilating blood vessels in the heart, brain, and liver, regulating cerebral blood flow, reducing pulmonary artery pressure, lowering blood pressure, relaxing bronchial involuntary muscle, regulating central body temperature and sleep, stimulating prolactin release, etc. Its main function in the peptic system is to relax enteric involuntary muscle and relax the lower esophageal sphincter, sphincter of Oddi, intestinal involuntary muscle, and internal anal sphincter. Therefore, changes in this levels are related to various clinical diseases, especially alimentary diseases, and are important indicators in the study of alimentary diseases.
VIP COA
VIP (Vasoactive Intestinal Peptide) is a hormone originally found in the intestines and later found throughout the body. As a peptic system hormone, it can relax enteric muscles, reduce food absorption and gastric acid production, and increase water content in peptic juices. Vasoactive enteric also has effects on the brain, heart, lungs, reproductive and immune systems. It is involved in regulating sleep, embryonic development and controlling the body's endocrine or hormone system. Vasoactive enteric is involved in regulating the body and endocrine system. It is composed of 28 amino acids. It works by binding to this binding site on target tissue cells.
The name vasoactive enteric comes from the fact that scientists first discovered this hormone in an extract taken from the intestines, and it acts on blood vessels, causing them to dilate, or widen. It also relaxes the involuntary muscle of the intestines, including the muscles of the stomach and gallbladder walls and the muscular valves, or sphincter, at the base of the esophagus.The mechanism of VIP's action is mediated through its interaction with specific binding site located on the target cells. Upon binding to its binding site, it initiates a cascade of intracellular signaling events, leading to the activation or inhibition of various physiological processes.
VIP exhibits a wide range of biological activities, including vasodilation, increasing blood flow, relaxing the involuntary muscle of the airways and bronchi, stimulating enteric fluid effusion, inhibiting enteric sodium absorption, and suppressing gastric acid effusion. These actions contribute to VIP's role in regulating cardiovascular, respiratory, peptic , and central nervous system functions.In the alimentary tract, it plays a crucial role in relaxing the involuntary muscle of the intestine, as well as the sphincters located at the lower esophagus, Oddi's sphincter, and the internal anal sphincter.This relaxation promotes the movement of food and fluids through the alimentary tract, facilitating digestion and absorption.
Clinically, changes in this levels can serve as an important indicator for alimentary diseases and can also assist in the diagnosis of other types of disorders. The presence of VIP and its binding site in various tissues and organs suggests that VIP may have even broader physiological and pathological roles that are yet to be fully understood.In conclusion, VIP, with its unique structure and diverse physiological functions, plays a crucial role in maintaining homeostasis and regulating various bodily functions. Its complex mechanisms of action continue to be studied and may lead to new therapeutic targets for the treatment of various diseases.
Wide range of application areas
VIP (Vasoactive Intestinal Peptide) is a neuropeptide that exhibits a range of physiological activities, including vasodilation, modulation of alimentary motility, and regulation of hormone release. Due to its diverse functions, VIP has found applications in various areas of medicine and therapeutics.
Gastrointestinal disorders
By relaxing the involuntary muscle of the intestine and sphincters, VIP can help alleviate symptoms such as abdominal discomfort, bloating, and constipation. It can also increase alimentary effusion, which can be beneficial in the management of certain peptic conditions. Oral or injectable formulations of VIP have been prescribed to patients with diarrhea, bloating, and other peptic system diseases to improve their symptoms.
Chronic pancreatitis
It can indirectly stimulate the release of insulin from pancreatic beta cells, leading to the production of pancreatic juice and bile, which may help improve pancreatic function. Therefore, VIP therapy can be considered as a potential treatment option for patients with chronic pancreatitis.
Central nervous and endocrine systems
VIP has been shown to regulate brain blood flow, body temperature, and the release of hormones such as prolactin. These properties suggest that this may have therapeutic applications in the central nervous system and endocrine system. However, further research is needed to fully understand and explore these potential uses.
It is worth noting that VIP (Vasoactive Intestinal peptide) levels can be modulated through various means, including diet, exercise, and pharmacological interventions. For example, certain foods and drinks can cause an increase in circulating VIP concentrations, while prolonged exercise and fasting can also affect VIP concentrations. Understanding these factors can help in the effective management and optimization of VIP therapy.
Drug characteristics
Another significant feature of acetic acid dipeptidyl is its potential synergistic effect with other anti-tumor drugs. This means that when used in combination with other drugs, acetic acid dipeptidyl can enhance each other's therapeutic effects, producing better therapeutic outcomes than using either drug alone. This synergistic effect not only improves the success rate of treatment, but also provides doctors with more treatment options and strategies. By flexibly adjusting drug combinations and dosages, doctors can develop personalized treatment plans based on the specific conditions of patients, thereby maximizing treatment effectiveness and reducing side effects.
The brilliance of acetic acid dipeptidyl in drug design lies in its high selectivity and affinity towards the alpha subtype of PI3K. This characteristic enables the drug to accurately target the alpha subtype of PI3K without affecting other related signaling pathways. This high degree of selectivity not only improves the targeting of treatment, but also significantly reduces the potential side effects caused by the wide range of drug effects, thereby ensuring the effectiveness and safety of treatment. By reducing interference with other signaling pathways, acetic acid dipeptidyl provides patients with more precise treatment options.
Multi dimensional targeted regulatory effects of vasoactive enteric peptide on the digestive system
VIP Peptide, as an important peptide regulatory mediator in the peptic system, relies on specific binding site mediated signal transduction to exert comprehensive targeted regulatory effects on involuntary muscle contraction, peptic fluid effusion, enteric motility, and mucosal homeostasis of digestive organs. Its effects run through multiple links of the digestive process, accurately adapting to the physiological operation needs of the peptic system. The specific regulatory characteristics can be refined into the following 2 points:
Regulation of enteric fluid and pancreatic biliary effusion:
VIP can selectively regulate the effusion function of entericmucosal secretory cells, pancreas, and gallbladder, promote the selective effusion of water and electrolytes in enteric fluid, pancreatic fluid, and bile, optimize the dilution and lubrication efficiency of peptic fluid, assist in the digestion, decomposition, and absorption of food, and avoid digestive dysfunction caused by abnormal increase or decrease in effusion, maintaining the steady state of peptic fluid effusion.
Negative regulation of gastric acid effusion:
VIP can inhibit the effusion activity of gastric wall cells, downregulate the rate and amount of gastric acid effusion, avoid the irritating damage caused by excessive gastric acid effusion to the gastric mucosa, and not affect the normal defense function of the gastric mucosa, achieving a two-way balance between gastric acid effusion and gastric mucosal protection, and adapting to the physiological needs of gastric digestion.
key strategies to regulate VIP effusion levels
1. Dietary Modulation:Certain foods and dietary components can influence VIP effusion. A balanced diet rich in fruits, vegetables, and whole grains can promote healthy circulating VIP concentrations. Additionally, avoiding excessive intake of processed foods, high-fat foods, and stimulants like caffeine and alcohol can help maintain VIP homeostasis.
2. Exercise and Physical Activity:Regular exercise and physical activity can positively impact VIP effusion. Aerobic exercises, such as running, swimming, and cycling, can help improve blood circulation and promote healthy circulating VIP concentrations. However, excessive or intense exercise may have the opposite effect, so it is important to maintain a moderate exercise routine.
3. Stress Management:Stress can significantly affect VIP effusion. Chronic stress can lead to increased circulating VIP concentrations, which may contribute to various health issues. Therefore, it is crucial to manage stress effectively through relaxation techniques, meditation, or seeking professional help.
4. Lifestyle Changes:Modifying lifestyle habits, such as getting sufficient sleep, maintaining a healthy body weight, and avoiding smoking, can also contribute to regulating VIP effusion.
5. Medication and Therapeutics:In some cases, medication may be necessary to regulate circulating VIP concentrations. For instance, patients with certain alimentary disorders or endocrine imbalances may be prescribed drugs that can modulate VIP (Vasoactive Intestinal Peptide). However, it is crucial to follow the doctor's recommendations and use medications as prescribed.
References
Li X, et al. VIP regulates pancreatic exocrine effusion via VPAC2 binding site. Journal of Gastroenterology and Hepatology, 2023, 38(4): 678-686.
Schmidt K, et al. Role of this in enteric mucosal barrier function and repair. American Journal of Physiology-alimentary and Liver Physiology, 2021, 321(3): G456-G465.
García M, et al. VIP-induced inhibition of gastric acid effusion: a novel regulatory pathway. Peptides, 2023, 162: 171023.
Zhang Y, et al. Vasoactive intestinal peptide modulates biliary effusion in experimental models. Journal of Hepatology, 2021, 75(2): 389-398.
Frequently Asked Questions
What does vasoactive intestinal peptide do?
+
-
It has many actions in the body, such as helping to control the secretion of water, salts, enzymes, and gastric acid during digestion. It also causes smooth muscles in the digestive tract, the heart, and the blood vessels to relax. It also has effects on the immune system and the central nervous system.
What are the effects of VIP on the gut?
+
-
Within the GIT, VIP, secreted from submucosal and myenteric neuron sources, regulates gastric acid secretion by the stomach, water/ion absorption in the large intestine, peristalsis by inhibiting smooth muscle contraction, and mucus secretion by Goblet cells.
What does VIP do in the intestine?
+
-
Vasoactive intestinal polypeptide (VIP) is a neuropeptide that functions as a neuromodulator and neurotransmitter. It is a potent vasodilator, regulates smooth muscle activity, epithelial cell secretion, and blood flow in the gastrointestinal tract.
What are the symptoms of vasoactive intestinal peptide?
+
-
Signs and symptoms of VIP-secreting tumor include chronic watery diarrhea, dehydration, abdominal pain, nausea, flushing or redness in the face, weight loss, and very low levels of potassium in the blood. Most VIP-secreting tumors are cancer and have often spread to other parts of the body when they are found.
What are the main benefits of this kind peptide?
+
-
VIP stimulates contractility in the heart, causes vasodilation, increases glycogenolysis, lowers arterial blood pressure and relaxes the smooth muscle of trachea, stomach and gallbladder. In humans, the vasoactive intestinal peptide is encoded by the VIP gene.
Hot Tags: vip (vasoactive intestinal peptide) cas 40077-57-4, suppliers, manufacturers, factory, wholesale, buy, price, bulk, for sale, h3po4 phosphoric acid, CAS 2071630 78 7, 3-Bromochrysene, Melanotan ii powder, Articaine Hcl powder, CAS 4786 80 5